{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:15:18Z","timestamp":1781583318933,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12012-022-09724-y","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T08:02:34Z","timestamp":1644480154000},"page":"246-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Unraveling the Differentially Articulated Axes of the Century-Old Renin\u2013Angiotensin\u2013Aldosterone System: Potential Therapeutic Implications"],"prefix":"10.1007","volume":"22","author":[{"given":"Pitchai","family":"Balakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaminder","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noohu Abdulla","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Sulochana","family":"LakshmiRaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Thangathirupathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karupiah","family":"Sundram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"issue":"16","key":"9724_CR1","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.3390\/ijms22168994","volume":"22","author":"H Sutanto","year":"2021","unstructured":"Sutanto, H., Dobrev, D., & Heijman, J. (2021). Angiotensin receptor-neprilysin inhibitor (ARNI) and cardiac arrhythmias. International Journal of Molecular Sciences, 22(16), 8994.","journal-title":"International Journal of Molecular Sciences"},{"key":"9724_CR2","doi-asserted-by":"crossref","first-page":"105929","DOI":"10.1016\/j.phrs.2021.105929","volume":"174","author":"P Balakumar","year":"2021","unstructured":"Balakumar, P., & Jagadeesh, G. (2021). The renin-angiotensin-aldosterone system: A century-old diversified system with several therapeutic avenues. Pharmacological Research, 174, 105929.","journal-title":"Pharmacological Research"},{"issue":"9","key":"9724_CR3","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.3390\/ijms22094762","volume":"22","author":"M Adamcova","year":"2021","unstructured":"Adamcova, M., Kawano, I., & Simko, F. (2021). The impact of microRNAs in renin-angiotensin-system-induced cardiac remodelling. International Journal of Molecular Sciences, 22(9), 4762.","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"9724_CR4","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.cellsig.2014.06.011","volume":"26","author":"P Balakumar","year":"2014","unstructured":"Balakumar, P., & Jagadeesh, G. (2014). A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology. Cellular Signalling, 26(10), 2147\u20132160.","journal-title":"Cellular Signalling"},{"issue":"5","key":"9724_CR5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/FJC.0b013e3181f21576","volume":"56","author":"P Balakumar","year":"2010","unstructured":"Balakumar, P., & Jagadeesh, G. (2010). Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: Promising young players from the old renin-angiotensin-aldosterone system. Journal of Cardiovascular Pharmacology, 56(5), 570\u2013579.","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"9724_CR6","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/JME-14-0125","volume":"53","author":"P Balakumar","year":"2014","unstructured":"Balakumar, P., & Jagadeesh, G. (2014). Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor. Journal of Molecular Endocrinology, 53(2), R71-92.","journal-title":"Journal of Molecular Endocrinology"},{"issue":"8","key":"9724_CR7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.cellsig.2012.04.003","volume":"24","author":"G Jagadeesh","year":"2012","unstructured":"Jagadeesh, G., Balakumar, P., & Stockbridge, N. (2012). How well do aliskiren\u2019s purported mechanisms track its effects on cardiovascular and renal disorders? Cellular Signalling, 24(8), 1583\u20131591.","journal-title":"Cellular Signalling"},{"issue":"Pt A","key":"9724_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2017.07.003","volume":"125","author":"P Balakumar","year":"2017","unstructured":"Balakumar, P., Anand-Srivastava, M. B., & Jagadeesh, G. (2017). Renin-angiotensin-aldosterone: An inclusive, an invigorative, an interactive and an interminable system. Pharmacological Research, 125(Pt A), 1\u20133.","journal-title":"Pharmacological Research"},{"key":"9724_CR9","doi-asserted-by":"crossref","first-page":"104314","DOI":"10.1016\/j.phrs.2019.104314","volume":"146","author":"P Balakumar","year":"2019","unstructured":"Balakumar, P., Sambathkumar, R., Mahadevan, N., Muhsinah, A. B., Alsayari, A., Venkateswaramurthy, N., & Jagadeesh, G. (2019). A potential role of the renin-angiotensin-aldosterone system in epithelial-to-mesenchymal transition-induced renal abnormalities: Mechanisms and therapeutic implications. Pharmacological Research, 146, 104314.","journal-title":"Pharmacological Research"},{"issue":"3","key":"9724_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40256-018-00321-5","volume":"19","author":"Y Feng","year":"2019","unstructured":"Feng, Y., Huang, R., Kavanagh, J., Li, L., Zeng, X., Li, Y., & Fu, P. (2019). Efficacy and safety of dual blockade of the renin-angiotensin-aldosterone system in diabetic kidney disease: A meta-analysis. American Journal of Cardiovascular Drugs, 19(3), 259\u2013286.","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"35","key":"9724_CR11","doi-asserted-by":"crossref","first-page":"e26544","DOI":"10.1097\/MD.0000000000026544","volume":"100","author":"M Zhao","year":"2021","unstructured":"Zhao, M., Qu, H., Wang, R., Yu, Y., Chang, M., Ma, S., Zhang, H., Wang, Y., & Zhang, Y. (2021). Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials. Medicine (Baltimore), 100(35), e26544.","journal-title":"Medicine (Baltimore)"},{"key":"9724_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07248-1","author":"MH Strauss","year":"2021","unstructured":"Strauss, M. H., Hall, A. S., & Narkiewicz, K. (2021). The combination of beta-blockers and ACE inhibitors across the spectrum of cardiovascular diseases. Cardiovascular Drugs and Therapy. https:\/\/doi.org\/10.1007\/s10557-021-07248-1","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"9724_CR13","doi-asserted-by":"crossref","first-page":"119919","DOI":"10.1016\/j.lfs.2021.119919","volume":"284","author":"V Sep\u00falveda-Fragoso","year":"2021","unstructured":"Sep\u00falveda-Fragoso, V., Alexandre-Santos, B., Salles, A. C. P., Proen\u00e7a, A. B., de Paula Alves, A. P., V\u00e1zquez-Carrera, M., N\u00f3brega, A. C. L., Frantz, E. D. C., & Magliano, D. C. (2021). Crosstalk between the renin-angiotensin system and the endoplasmic reticulum stress in the cardiovascular system: Lessons learned so far. Life Science, 284, 119919.","journal-title":"Life Science"},{"issue":"1","key":"9724_CR14","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1038\/s41467-020-18880-0","volume":"11","author":"H Jia","year":"2020","unstructured":"Jia, H., Yue, X., & Lazartigues, E. (2020). ACE2 mouse models: A toolbox for cardiovascular and pulmonary research. Nature Communications, 11(1), 5165.","journal-title":"Nature Communications"},{"issue":"19","key":"9724_CR15","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1042\/CS20200483","volume":"134","author":"M Mohammed","year":"2020","unstructured":"Mohammed, M., Berdasco, C., & Lazartigues, E. (2020). Brain angiotensin converting enzyme-2 in central cardiovascular regulation. Clinical Science (London, England), 134(19), 2535\u20132547.","journal-title":"Clinical Science (London, England)"},{"issue":"2","key":"9724_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/hr.2009.201","volume":"33","author":"AH Nabi","year":"2010","unstructured":"Nabi, A. H., & Suzuki, F. (2010). Biochemical properties of renin and prorenin binding to the (pro)renin receptor. Hypertension Research, 33(2), 91\u201397.","journal-title":"Hypertension Research"},{"issue":"8","key":"9724_CR17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ajh.2011.246","volume":"25","author":"A Kurtz","year":"2012","unstructured":"Kurtz, A. (2012). Control of renin synthesis and secretion. American Journal of Hypertension, 25(8), 839\u2013847.","journal-title":"American Journal of Hypertension"},{"key":"9724_CR18","doi-asserted-by":"crossref","first-page":"105890","DOI":"10.1016\/j.phrs.2021.105890","volume":"173","author":"P Balakumar","year":"2021","unstructured":"Balakumar, P., Alqahtani, A., Khan, N. A., Alqahtani, T., & Jagadeesh, G. (2021). The physiologic and physiopathologic roles of perivascular adipose tissue and its interactions with blood vessels and the renin-angiotensin system. Pharmacological Research, 173, 105890.","journal-title":"Pharmacological Research"},{"issue":"1","key":"9724_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5049\/EBP.2008.6.1.42","volume":"6","author":"HE Yim","year":"2008","unstructured":"Yim, H. E., & Yoo, K. H. (2008). Renin-Angiotensin system\u2014Considerations for hypertension and kidney. Electrolyte Blood Press, 6(1), 42\u201350.","journal-title":"Electrolyte Blood Press"},{"issue":"11","key":"9724_CR20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/hr.2011.113","volume":"34","author":"P Balakumar","year":"2011","unstructured":"Balakumar, P., & Jagadeesh, G. (2011). Potential cross-talk between (pro)renin receptors and Wnt\/frizzled receptors in cardiovascular and renal disorders. Hypertension Research, 34(11), 1161\u20131170.","journal-title":"Hypertension Research"},{"key":"9724_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105922","author":"N Hoffmann","year":"2021","unstructured":"Hoffmann, N., & Peters, J. (2021). Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: Pathological implications in hypertension, renal and brain development, inflammation, and fibrosis. Pharmacological Research. https:\/\/doi.org\/10.1016\/j.phrs.2021.105922","journal-title":"Pharmacological Research"},{"key":"9724_CR22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2013.00201","volume":"4","author":"MC Chappell","year":"2014","unstructured":"Chappell, M. C., Marshall, A. C., Alzayadneh, E. M., Shaltout, H. A., & Diz, D. I. (2014). Update on the angiotensin converting enzyme 2-angiotensin (1\u20137)-MAS receptor axis: Fetal programing, sex differences, and intracellular pathways. Front Endocrinol (Lausanne)., 4, 201.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"9","key":"9724_CR23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/0929866524666170728151401","volume":"24","author":"A Nunes-Silva","year":"2017","unstructured":"Nunes-Silva, A., Rocha, G. C., Magalhaes, D. M., Vaz, L. N., Salviano de Faria, M. H., & Simoes E Silva, A. C. (2017). Physical exercise and ACE2-angiotensin-(1\u20137)-Mas receptor axis of the renin angiotensin system. Protein & Peptide Letters, 24(9), 809\u2013816.","journal-title":"Protein & Peptide Letters"},{"issue":"7","key":"9724_CR24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai, M., & Horiuchi, M. (2009). Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs ACE2-angiotensin-(1\u20137)-Mas receptor axis. Hypertension Research, 32(7), 533\u2013536.","journal-title":"Hypertension Research"},{"issue":"4","key":"9724_CR25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","volume":"71","author":"LB Arendse","year":"2019","unstructured":"Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Jr., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019). Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacological Reviews, 71(4), 539\u2013570.","journal-title":"Pharmacological Reviews"},{"issue":"8","key":"9724_CR26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel, V. B., Zhong, J. C., Grant, M. B., & Oudit, G. Y. (2016). Role of the ACE2\/Angiotensin 1\u20137 Axis of the renin-angiotensin system in heart failure. Circulation Research, 118(8), 1313\u20131326.","journal-title":"Circulation Research"},{"issue":"7","key":"9724_CR27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/10641963.2020.1772812","volume":"42","author":"W Han","year":"2020","unstructured":"Han, W., Wang, M., Zhai, X., Gan, Q., Guan, S., & Qu, X. (2020). Chemical renal denervation-induced upregulation of the ACE2\/Ang (1\u20137)\/Mas axis attenuates blood pressure elevation in spontaneously hypertensive rats. Clinical and Experimental Hypertension, 42(7), 661\u2013668.","journal-title":"Clinical and Experimental Hypertension"},{"issue":"11","key":"9724_CR28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","volume":"18","author":"TR Rodrigues Prestes","year":"2017","unstructured":"Rodrigues Prestes, T. R., Rocha, N. P., Miranda, A. S., Teixeira, A. L., & Simoes-E-Silva, A. C. (2017). The anti-inflammatory potential of ACE2\/Angiotensin-(1\u20137)\/Mas receptor axis: Evidence from basic and clinical research. Current Drug Targets, 18(11), 1301\u20131313.","journal-title":"Current Drug Targets"},{"key":"9724_CR29","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.phrs.2021.105924","volume":"174","author":"D Gupta","year":"2021","unstructured":"Gupta, D., Kumar, A., Mandloi, A., & Shenoy, V. (2021). Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities. Pharmacological Research, 174, 105924.","journal-title":"Pharmacological Research"},{"issue":"Pt A","key":"9724_CR30","first-page":"21","volume":"125","author":"XC Li","year":"2017","unstructured":"Li, X. C., Zhang, J., & Zhuo, J. L. (2017). The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacological Research, 125(Pt A), 21\u201338.","journal-title":"Pharmacological Research"},{"key":"9724_CR31","doi-asserted-by":"crossref","first-page":"1704762","DOI":"10.1155\/2021\/1704762","volume":"2021","author":"G Yao","year":"2021","unstructured":"Yao, G., Li, W., Liu, W., Xing, J., & Zhang, C. (2021). The level and significance of circulating angiotensin-III in patients with coronary atherosclerosis. Journal of the Renin-Angiotensin-Aldosterone System, 2021, 1704762.","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"issue":"9","key":"9724_CR32","doi-asserted-by":"crossref","first-page":"e012644","DOI":"10.1161\/JAHA.119.012644","volume":"8","author":"JL Zhuo","year":"2019","unstructured":"Zhuo, J. L., & Li, X. C. (2019). Angiotensin III\/AT2 receptor\/NHE3 signaling pathway in the proximal tubules of the kidney: A novel natriuretic and antihypertensive mechanism in hypertension. Journal of the American Heart Association, 8(9), e012644.","journal-title":"Journal of the American Heart Association"},{"key":"9724_CR33","first-page":"166","volume":"4","author":"JL Zhuo","year":"2013","unstructured":"Zhuo, J. L., Ferrao, F. M., Zheng, Y., & Li, X. C. (2013). New frontiers in the intrarenal renin-angiotensin system: A critical review of classical and new paradigms. Front Endocrinol (Lausanne)., 4, 166.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"21","key":"9724_CR34","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s00018-004-4246-1","volume":"61","author":"SY Chai","year":"2004","unstructured":"Chai, S. Y., Fernando, R., Peck, G., Ye, S. Y., Mendelsohn, F. A., Jenkins, T. A., & Albiston, A. L. (2004). The angiotensin IV\/AT4 receptor. Cellular and Molecular Life Sciences, 61(21), 2728\u20132737.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"9724_CR35","first-page":"e29C-3","volume":"261","author":"MKS Wong","year":"2016","unstructured":"Wong, M. K. S. (2016). Other angiotensins. Handbook of Hormones, 261, e29C-3.","journal-title":"Handbook of Hormones"},{"issue":"9","key":"9724_CR36","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1096\/fj.11-185470","volume":"25","author":"V Jankowski","year":"2011","unstructured":"Jankowski, V., T\u00f6lle, M., Santos, R. A., G\u00fcnthner, T., Krause, E., Beyermann, M., Welker, P., Bader, M., Pinheiro, S. V., Sampaio, W. O., Lautner, R., Kretschmer, A., van der Giet, M., Zidek, W., & Jankowski, J. (2011). Angioprotectin: An angiotensin II-like peptide causing vasodilatory effects. The FASEB Journal, 25(9), 2987\u20132995.","journal-title":"The FASEB Journal"},{"issue":"8","key":"9724_CR37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","volume":"112","author":"RQ Lautner","year":"2013","unstructured":"Lautner, R. Q., Villela, D. C., Fraga-Silva, R. A., Silva, N., Verano-Braga, T., Costa-Fraga, F., Jankowski, J., Jankowski, V., Sousa, F., Alzamora, A., Soares, E., Barbosa, C., Kjeldsen, F., Oliveira, A., Braga, J., Savergnini, S., Maia, G., Peluso, A. B., Passos-Silva, D., \u2026 Santos, R. A. (2013). Discovery and characterization of alamandine: A novel component of the renin-angiotensin system. Circulation Research, 112(8), 1104\u20131111.","journal-title":"Circulation Research"},{"issue":"2","key":"9724_CR38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.mnh.0000441052.44406.92","volume":"23","author":"DC Villela","year":"2014","unstructured":"Villela, D. C., Passos-Silva, D. G., & Santos, R. A. (2014). Alamandine: A new member of the angiotensin family. Current Opinion in Nephrology and Hypertension, 23(2), 130\u2013134.","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"2","key":"9724_CR39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.ATV.0000253889.09765.5f","volume":"27","author":"V Jankowski","year":"2007","unstructured":"Jankowski, V., Vanholder, R., van der Giet, M., T\u00f6lle, M., Karadogan, S., Gobom, J., Furkert, J., Oksche, A., Krause, E., Tran, T. N., Tepel, M., Schuchardt, M., Schl\u00fcter, H., Wiedon, A., Beyermann, M., Bader, M., Todiras, M., Zidek, W., & Jankowski, J. (2007). Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(2), 297\u2013302.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"5","key":"9724_CR40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/HYPERTENSIONAHA.110.161836","volume":"57","author":"R Yang","year":"2011","unstructured":"Yang, R., Smolders, I., Vanderheyden, P., Demaegdt, H., Van Eeckhaut, A., Vauquelin, G., Lukaszuk, A., Tourw\u00e9, D., Chai, S. Y., Albiston, A. L., Nahmias, C., Walther, T., & Dupont, A. G. (2011). Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent. Hypertension, 57(5), 956\u2013964.","journal-title":"Hypertension"},{"issue":"6","key":"9724_CR41","first-page":"4553","volume":"19","author":"L Wang","year":"2019","unstructured":"Wang, L., Liu, C., Chen, X., & Li, P. (2019). Alamandine attenuates long-term hypertension-induced cardiac fibrosis independent of blood pressure. Molecular Medicine Reports, 19(6), 4553\u20134560.","journal-title":"Molecular Medicine Reports"},{"issue":"6","key":"9724_CR42","doi-asserted-by":"crossref","first-page":"C702","DOI":"10.1152\/ajpcell.00153.2017","volume":"314","author":"ICG Jesus","year":"2018","unstructured":"Jesus, I. C. G., Scalzo, S., Alves, F., Marques, K., Rocha-Resende, C., Bader, M., Santos, R. A. S., & Guatimosim, S. (2018). Alamandine acts via MrgD to induce AMPK\/NO activation against ANG II hypertrophy in cardiomyocytes. American Journal of Physiology. Cell Physiology, 314(6), C702\u2013C711.","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"9724_CR43","doi-asserted-by":"crossref","first-page":"173384","DOI":"10.1016\/j.ejphar.2020.173384","volume":"883","author":"C Yang","year":"2020","unstructured":"Yang, C., Wu, X., Shen, Y., Liu, C., Kong, X., & Li, P. (2020). Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway. European Journal of Pharmacology, 883, 173384.","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"9724_CR44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/CS20180547","volume":"133","author":"FP de Souza-Neto","year":"2019","unstructured":"de Souza-Neto, F. P., Silva, M. M. E., Santuchi, M. C., de Alc\u00e2ntara-Leon\u00eddio, T. C., Motta-Santos, D., Oliveira, A. C., Melo, M. B., Canta, G. N., de Souza, L. E., Irigoyen, M. C. C., Campagnole-Santos, M. J., Guatimosim, S., Santos, R. A. S., & da Silva, R. F. (2019). Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice. Clinical Science (London, England), 133(5), 629\u2013643.","journal-title":"Clinical Science (London, England)"},{"issue":"1","key":"9724_CR45","doi-asserted-by":"crossref","first-page":"H352","DOI":"10.1152\/ajpheart.00328.2020","volume":"320","author":"MM Silva","year":"2021","unstructured":"Silva, M. M., de Souza-Neto, F. P., Jesus, I. C. G., Gon\u00e7alves, G. K., Santuchi, M. C., Sanches, B. L., de Alc\u00e2ntara-Leon\u00eddio, T. C., Melo, M. B., Vieira, M. A. R., Guatimosim, S., Santos, R. A. S., & da Silva, R. F. (2021). Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice. American Journal of Physiology. Heart and Circulatory Physiology, 320(1), H352\u2013H363.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"9724_CR46","doi-asserted-by":"crossref","first-page":"9975315","DOI":"10.1155\/2021\/9975315","volume":"2021","author":"RS Fernandes","year":"2021","unstructured":"Fernandes, R. S., Dias, H. B., de Souza Jaques, W. A., Becker, T., & Rigatto, K. (2021). Assessment of alamandine in pulmonary fibrosis and respiratory mechanics in rodents. Journal of the Renin-Angiotensin-Aldosterone System, 2021, 9975315.","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"issue":"9","key":"9724_CR47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1139\/cjpp-2020-0662","volume":"99","author":"Q Liu","year":"2021","unstructured":"Liu, Q., Zheng, B., Zhang, Y., Huang, W., Hong, Q., & Meng, Y. (2021). Alamandine via MrgD receptor attenuates pulmonary fibrosis via NOX4 and autophagy pathway. Canadian Journal of Physiology and Pharmacology, 99(9), 885\u2013893.","journal-title":"Canadian Journal of Physiology and Pharmacology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09724-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-022-09724-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09724-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T06:50:30Z","timestamp":1726642230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-022-09724-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["9724"],"URL":"https:\/\/doi.org\/10.1007\/s12012-022-09724-y","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}